Home

>

R&D

 >

 Generics

Generics


Lupin's process research addresses patented and non-patented markets. We have a proven track record of developing cost-effective, eco-friendly and non-infringing technologies that involve complex chemistry. 

Among our achievements in process chemistry:

  • Successful ANDA filings for ceftriaxone, cefixime, cefuroxime axetil and cefotaxime 

  • Submission of 12 drug master files (DMF)

  • Development of a pipeline of products in cephalosporins, and cardiovascular therapies including 'prils' and 'statins'